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Background: The lack of prognostic biomarkers in oral squamous cell carcinoma (OSCC) has hampered treatment
decision making and survival in OSCC remains poor. Histopathological features are used for prognostication in
OSCC and, although useful for predicting risk, manual assessment of histopathology is subjective and labour
intensive. In this study, we propose a method that integrates multiple histopathological features of the tumor
microenvironment into a single, digital pathology-based biomarker using nuclear fractal dimension (nFD) analysis.
Methods: One hundred and seven consecutive OSCC patients diagnosed between 1998 and 2006 in Calgary,
Canada were included in the study. nFD scores were generated from DAPI-stained images of tissue microarray
(TMA) cores. Ki67 protein expression was measured in the tumor using fluorescence immunohistochemistry (IHC)
and automated quantitative analysis (AQUA®). Lymphocytic infiltration (LI) was measured in the stroma from
haematoxylin-eosin (H&E)-stained TMA slides by a pathologist.
Results: Twenty-five (23.4%) and 82 (76.6%) patients were classified as high and low nFD, respectively. nFD was
significantly associated with pathological tumor-stage (pT-stage; P = 0.01) and radiation treatment (RT; P = 0.01).
High nFD of the total tumor microenvironment (stroma plus tumor) was significantly associated with improved
disease-specific survival (DSS; P = 0.002). No association with DSS was observed when nFD of either the tumor or
the stroma was measured separately. pT-stage (P = 0.01), pathological node status (pN-status; P = 0.02) and RT
(P = 0.03) were also significantly associated with DSS. In multivariate analysis, nFD remained significantly associated
with DSS [HR 0.12 (95% CI 0.02-0.89, P = 0.04)] in a model adjusted for pT-stage, pN-status and RT. We also found
that high nFD was significantly associated with high tumor proliferation (P < 0.0001) and high LI (P < 0.0001), factors
that we and others have shown to be associated with improved survival in OSCC.
Conclusions: We provide evidence that nFD analysis integrates known prognostic factors from the tumor
microenvironment, such as proliferation and immune infiltration, into a single digital pathology-based biomarker.
Prospective validation of our results could establish nFD as a valuable tool for clinical decision making in OSCC.* Correspondence: mtambasco@mail.sdsu.edu; jdort@ucalgary.ca
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Almost 30 000 individuals are diagnosed with oral squa-
mous cell carcinoma (OSCC) each year in North America
and approximately 6000 of these patients succumb to the
disease, annually [1]. OSCC is an aggressive disease and
even favourable treatment outcomes are associated with
significant morbidity. Five-year survival rates for OSCC
have remained between 40 and 50% for the past several
decades. Biomarkers that can identify aggressive disease at
diagnosis and inform treatment decisions might improve
survival outcomes and quality of life for OSCC patients.
Although several prognostic markers for OSCC have been
described in the literature, treatment is directed predom-
inantly by the tumor-node-metastasis (TNM) staging
system.
The tumor microenviroment is a dynamically interact-
ing entity composed of tumor cells and the surrounding
stroma. These interactions are not only critical for tumor
growth and progression but also for treatment sensitivity/
resistance. Therefore, effective prognostic biomarkers
should ideally incorporate features of both tumor and
stroma, leading to a more comprehensive assessment of
tumor biology. Histopathological features have been
previously used for prognostication in OSCC. Brandwein-
Gensler and colleagues described a histologic risk assess-
ment score based on pattern of invasion (POI), perineural
invasion (PNI) and lymphocytic infiltration (LI) [2,3].
These authors propose that achieving negative resection
margins do not guarantee local disease-free and overall
survival benefits. On the other hand, a combination of
histopathological features of the tumor (POI and PNI) and
stroma (LI) accurately predicted risk of local recurrence
and survival. Although the manual assessment of histo-
logical features is a powerful technique for predicting risk,
it requires expert subject knowledge of head and neck
histopathology and can be very labour intensive. Since few
diagnostic laboratories have access to specialized head and
neck pathologists, integration of histological feature ana-
lysis into a single, digital histopathology-based biomarker
may improve the utility and encourage clinical adoption of
this type of prognostic testing.
Fractal dimension (FD) is a mathematical measure of
the irregularity and complexity of a shape and may be
used for the digital assessment and quantification of
histological features in the tumor microenvironment [4].
In contrast to our intuitive notion of dimension (i.e. the
topological dimension), which is an integer value (0 for a
point, 1 for a line, 2 for a plane, etc.), the FD can be a
non-integer value that is greater than the topological
dimension. The extent to which the FD of an object may
be greater than the topological dimension depends on
the space filling capacity of the object. FD is a non-
integer number that quantifies the degree of space filling
of an object. True mathematical fractals exhibit a higherdegree of space filling because they exhibit exact or
statistical self-similarity in structural patterns when
examined to infinitely small scales. As such, actual frac-
tals do not exist in nature, since there is a fundamental
natural limitation to the scaling behaviour of natural
objects [5]. However, FD analysis has found widespread
use in medical image analysis because it lends itself
naturally to the pragmatic characterization of irregular
non-Euclidean structures found in medical images [6,7].
One such application of FD has been to discriminate the
architectural complexity of biological structures associ-
ated with neoplastic states. Previous studies have applied
FD analysis for the diagnosis, staging and prognosis
of several cancer-types including breast [4,8], prostate
[9,10], colon [11], lung [12], endometrial [13], gall bladder
[14], larynx [15] and OSCC [16]. FD analysis of nuclear
histology digitally quantifies the space filling properties of
nuclei. Such analysis, when performed on the entire tumor
microenvironment (tumor and stroma) can be a source of
rich prognostic information.
We have previously used fluorescence immunohisto-
chemistry (IHC) and automated quantitative analysis
(AQUA®) to investigate the prognostic value of proteins
associated with apoptosis [17,18], proliferation [19] and
hypoxia [20,21] in OSCC. We have also reported that
the prognostic impact of these biomarkers differs
according to their cellular distribution within the tumor
microenvironment. Tissue microarrays (TMAs) used to
examine protein biomarkers are ideally-suited for digital
histological analysis since TMA cores contain both
tumor and stromal tissue compartments. When per-
forming AQUA®, images of each whole TMA core are
generated and the nuclei are routinely co-stained with
4′,6-diamidino-2-phenylindole (DAPI) to differentiate
nuclear/cytoplasmic localization of a biomarker. In this
study, we computed the fractal properties of DAPI-
stained nuclei in whole TMA cores. We hypothesized
that nFD analysis will integrate tumor and stromal char-
acteristics commonly incorporated in OSCC histopatho-
logical risk assessment methods into a single, prognostic
factor for OSCC. We report that nFD is a robust and
powerful independent prognosticator of patient outcome
that integrates the proliferative properties of the tumor
compartment and the immunologic properties of the
stromal compartment into a unified prognostic entity
that is amenable to clinical translation.
Methods
Patient cohort
This study conforms to the Tri-council Policy Statement
for Research with Human Subjects (Canada) and was
approved by the University of Calgary Conjoint Health
Research Ethics Board. Our retrospective study cohort
consisted of 107 histologically confirmed treatment











(LR P - value)
Number of
events
- - 33 1 - -
Gender 0.81 0.457
Male 70 65.42 53 17
Female 37 34.58 29 8
Age 107 NA 61.1b 59.8b 0.68 nd
pT-Stage 0.01 0.01
pT1/pT2 (low) 61 57.01 41 20
pT3/pT4 (high) 44 41.12 40 4
Missing 2 1.87 1 1
pN-status 0.25 0.02
pN0 66 61.68 48 18




Never 28 26.168 20 8
Ever 78 72.897 61 17




Never 11 10.28 10 1
Ever 57 53.27 43 14




Well 15 14.02 10 5
Moderate 56 52.34 47 9
Poor 12 11.21 9 3
Missing 24 22.43 16 8
Treatment 0.01 0.03
Surgery 34 31.78 20 14
Surgery + RT 73 68.22 62 11
Ki67
Low 43 76.19 40 3 0.001 0.002
High 62 23.81 40 22
LI
Low 53 50.47 48 5 0.001 0.002
High 52 49.43 32 20
aCut-point was determined using X-tile.
bMean age.
nFD: nuclear fractal dimension; pT-stage: pathological T-stage; pN status:
pathological node status; RT: radiotherapy; FE: Fisher’s exact; LR: logrank, LI:
lymphocytic infiltration. Significant P - values are shown in BOLD.
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tween 1998 and 2006 at the Foothills Medical Centre,
Calgary, Canada. Eligible patients had no prior history of
head and neck cancer. Patients received post-operative
radiotherapy based on the presence of metastatic lymph
nodes, extra-capsular spread or positive surgical margins.
Clinico-pathological characteristics of the patient cohort
are described in Table 1.
Tissue microarray (TMA) construction
Archived formalin-fixed paraffin-embedded (FFPE) tumor
blocks were retrieved for TMA construction. Haematoxylin-
eosin (H&E)-stained slides were reviewed by the study
pathologist (KG) to select blocks with sufficient tumor con-
tent. For each patient included in the study, three 0.6 mm
cores were randomly sampled from the tumour-bearing
areas of selected FFPE block using a Beecher Manual
Tissue Microarrayer (Beecher Instruments Inc. WI, USA).
Approximately 100 patients (each with triplicate cores)
were included on a TMA block. Slides were assembled
using 4 μm thick sections from the TMA block.
Fractal dimension analysis
TMAs were immunofluorescently stained as previously
described [18]. High resolution images of nuclei, defined
by positive DAPI-stained regions, for each TMA core were
collected for subsequent analysis as part the automated
quantitative analysis (AQUA®) process. Images were ac-
quired at 20X magnification corresponding to a resolution
of 0.468 μm/pixel and saved in tagged image file format
(.tiff) for fractal analysis. Cores were excluded from ana-
lysis if they were out of focus, tissue was folded, or there
was insufficient tumor present (less than 100 tumor cells).
We applied an automated fractal analysis technique
that we developed in previous work [5,10] to quantify
the degree of space filling of nuclei. In summary, this
technique involves the following steps:
1. Application of a series of intensity thresholds to
convert the acquired grey-scale DAPI images (from
AQUA®) into a series of binary images to derive the
outlines of nuclei.
2. Application of the box counting method (with
appropriate spatial scale range for our structures of
interest – nominally ~4 to 60 μm) [5,10] to compute
the fractal dimension of each outline image obtained
from step 3.
3. Identification of the global maximum from a plot of
fractal dimension versus intensity threshold. This
maximum corresponds to the fractal dimension of
the pathological structures [10].
Our automated fractal analysis method was applied to
a total of 321 TMA cores (3 cores for each of the 107patient samples), and for each patient the mean nFD
from the three TMA cores was used in statistical
analyses.
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Ki67 staining has been described previously [19]. Briefly,
TMAs were stained for DAPI (Invitrogen), Ki67 (mouse
monoclonal, clone MIB1, DAKO) and Pan-cytokeratin
(PCK; guinea pig polyclonal, ACRIS). We used the
Aperio Scanscope® FL slide scanner for automated fluor-
escent image acquisition and HistoRx AQUAnalysis®
software version 2.3.4.1 for automated image analysis.
Lymphocytic infiltration
H&E stained OSCC TMA cores were evaluated for the
presence of LI at the invasive boundary of the tumor at
200X microscope magnification by the study pathologist
(KG). All mononuclear cells including lymphocytes and
plasma cells were scored (granulocytes and other poly-
morphonuclear leukocytes were excluded). Necrotic
areas near the invasive tumor boundaries were excluded
from LI assessment. LI was classified as a four-tiered
variable: zero infiltration, weak infiltration, intermediate
infiltration and strong infiltration. For each patient, the
maximum value of the LI among three TMA cores was
used for statistical analyses.
Statistical analysis
X-Tile version 3.6.1 software was used to determine op-
timal cut-points to dichotomize continuous nFD scores
[22]. In Table 1, Fisher’s exact test was used to compare
clinical covariates between the two patient groups de-
fined by low or high nFD. Kaplan-Meier curves and Cox
proportional hazards models were used to assess associ-
ation with 5-year disease-specific survival (DSS). Clinical
covariates that are usually associated with prognosis in
OSCC such as pathological T-stage (pT-stage) and
pathological node status (pN-status) were subjected to
Cox univariate analysis. Clinical covariates that were
significantly associated with DSS in univariate analysis
were included in a multivariate model with nFD. In all
analyses, a P-value of < 0.05 was considered statistically
significant. All statistical analyses were performed using
Stata 13 data analysis and statistical software (StataCorP
LP, College Station, Tx, USA).
Results
Cohort characteristics
Our study was conducted and reported according to
Reporting recommendations for tumor marker prognos-
tic studies (REMARK) criteria for reporting tumor bio-
marker prognostic studies [23]. The median age at
diagnosis for the study cohort was 62.35 years (range:
25.73 – 95.12 years). Median survival was 77.85 months;
survivor follow-up duration ranged between 1.3 and
156.9 months [standard deviation = 33.3]. All patients
were treated with primary surgery and 73 (68.2%) re-
ceived post-operative radiotherapy. Univariate analysesof the association of clinico-pathological variables with
DSS are presented in Table 1. pT-stage (P = 0.01),
pN-status (P = 0.02) and treatment (whether patients
received post-operative radiotherapy; P = 0.03) were
significantly associated with DSS. Patients with high
nFD did not differ significantly from patients with low
nFD in terms of age of diagnosis, gender, pN-status,
smoking history, alcohol history and tumor differenti-
ation status (Fisher’s exact test).
Fractal analysis of nuclei and survival analyses
nFD scores ranged between 1.19 and 1.84, with a median
of 1.52, lower quartile 1.42, and upper quartile 1.64.
Figure 1 shows representative monochromatic DAPI-
stained images of TMA cores with low (1.28), intermedi-
ate (1.47) and high (1.84) nFD. All TMA cores examined
contained nuclei from both the tumor and the stromal
tissue compartments. Twenty-five (23.4%) patients were
classified as high nFD and 82 (76.6%) were classified as
low nFD. Among the clinical covariates assessed, high
pT-stage was significantly associated with low nFD
scores (Fisher’s Exact P = 0.01; Table 1). Also, most
patients who received post-operative radiotherapy had
low nFD scores (Fisher’s Exact P = 0.01; Table 1). In our
entire cohort of 107 OSCC patients, high nFD was asso-
ciated with significantly better DSS compared to low
nFD (Figure 2A); the HR estimate was 0.09 (95% CI,
0.01 to 0.64), reflecting a 91% reduction in DSS non-
achievement in patients with high nFD (P = 0.02;
Table 2). A significant association between nFD and DSS
was also observed when the analysis was restricted to
patients who received post-operative radiotherapy (73
patients; logrank P = 0.01; Figure 2B); no association be-
tween nFD and DSS was observed in patients who were
treated with surgery alone (logrank P = 0.26; Figure 2C).
Furthermore, nFD remained an independent prognostic
factor in our OSCC cohort [HR 0.11 (95% CI, 0.02 to
0.83), P = 0.03] after adjusting for other known prognos-
tic factors including pT-stage [HR 2.26 (95% CI 1.10 to
4.50, P = 0.02)] and pN-status [HR 2.14 (95% CI 1.10 to
4.30, P = 0.03)] (Table 2). The nFD of the tumor compart-
ment or stromal compartment alone were not significantly
associated with survival (data not shown).
Association between nFD and tumor proliferation
We have previously reported that increased tumor cell
proliferation in OSCC is associated with significantly
better survival that may be attributed to an improved
response to post-operative radiotherapy [19]. Tumor pro-
liferation was assessed by Ki67 staining of nuclei in the
PCK-stained tumor compartment. Figure 3A shows repre-
sentative images of DAPI-stained nuclei from TMA cores
within the PCK-stained tumor compartment and corre-
sponding H&E-stained slides from the same patient. The
Figure 1 Representative DAPI-stained images of individual tissue microarray (TMA) cores used as substrates for nuclear fractal dimension (nFD)
analysis. Image of an entire TMA core with (A) low nFD, (B) intermediate nFD and (C) high nFD.
Figure 2 Five-year disease-specific survival (DSS) in OSCC patients stratified by nuclear fractal dimension (nFD). Kaplan-Meier curves for DSS by
nFD in (A) all patients, (B) patients who received radiotherapy after surgery and (C) patients who did not receive post-operative radiotherapy.
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Table 2 Univariate and multivariate analysis of 5-Year Disease-Specific Survival (DSS)
Univariate Multivariate
HR 95% CI P - value HR 95% CI P - value
nFD (low vs. high) 0.09 0.01 - 0.64 0.02 0.11 0.02 – 0.83 0.03
pT-stage (T1/T2 vs. T3/T4) 2.83 1.42 – 5.67 0.003 2.26 1.10 – 4.50 0.02
pN-status (N0 vs. N1/N2) 2.19 1.12 - 4.31 0.02 2.14 1.10 – 4.30 0.03
HR: hazard ratio; CI: confidence interval. HRs estimated from stratification of Cox proportional hazard models. Significant P - values are shown in BOLD.
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nFD was significantly higher in the high proliferative index
group (P < 0.0001).
Association between nFD and LI
In order to better understand how nFD is correlated with
characteristics of the tumor microenvironment, we stud-
ied the association between nFD and stromal LI. Figure 3C
shows representative fluorescent images of DAPI-stained
nuclei from TMA cores in the PCK-negative stromalFigure 3 Association between nuclear fractal dimension (nFD) and feature
images of TMA cores with high and low nFD (upper panels) and images o
plot showing the association between nFD and tumor proliferation. (C) Rep
(upper panels) and H & E-stained images of cores from the same patient th
(D) Box and whisker plot showing the association between nFD and LI.compartment with corresponding nFD scores (upper
panel) and H&E-stained TMA cores from the same pa-
tients showing LI (lower panel). Considerable heterogen-
eity in terms of LI scores was observed among TMA cores
from the same patient, ranging from weak infiltration in
one core to strong infiltration in another. The core show-
ing the maximum infiltration was used as the representa-
tive core for each patient. As evident from the box and
whisker plots (Figure 3D), nFD values were positively
correlated with increased LI in the stroma (P < 0.0001). Ins of the tumor microenvironment. (A) Representative DAPI-stained
f the same cores stained for Ki67 (lower panels). (B) Box and whisker
resentative DAPI-stained images of TMA cores with high and low nFD
at were used for assessing lymphocytic infiltration (LI; lower panels).
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associated with significantly improved survival in our
OSCC cohort (P = 0.001; Additional file 1: Figure S1).
Discussion
We report a digital histopathologal image-based prog-
nostic biomarker (nFD) derived from fractal analysis of
DAPI-stained nuclei. This single measure integrates
features of both the stromal and tumor compartments
in the tumor microenvironment. nFD can effectively dis-
criminate between OSCC patients with good and worse
prognosis and was an independent prognostic indicator
in our OSCC cohort when the model was adjusted for
established prognostic clinical covariates. A strong positive
correlation was observed between nFD and a pathologist-
scored assessment of LI in the stroma. nFD was also
positively correlated with proliferation (scored using fluor-
escence IHC and AQUA®), an important tumor-associated
prognostic marker. The significance of both these features,
independently, suggests that nFD scores are an effective
method for the automated, image-based, integration of
both stromal and tumor features with acknowledged prog-
nostic value.
OSCC is a serious public health problem worldwide
and the lack of effective prognostic biomarkers adversely
affects patient management and survival outcomes. This
has led researchers to look beyond the traditional TNM
staging system and investigate biological correlates to
histopathological features of the tumor microenviron-
ment. Staining with DAPI is a routine component of
IHC that helps identify nuclei. We hypothesized that FD
analysis of DAPI-stained images (computer-acquired
when performing AQUAnalysis®), could provide a digital
histology-based prognostic factor for OSCC that might
be more objective and less labour-intensive than trad-
itional histopathological analysis. FD analysis has been
previously used in OSCC. Several researchers have
demonstrated that FD can discriminate between normal
versus malignant oral tissue [27,28]. Goutzanis and col-
leagues have used FD to assess vascularization and also
nFD as a prognostic factor [16,29]. However, contrary to
our results, these authors report that high nFD is associ-
ated with poor prognosis [16]. It is worth noting that
almost all previously reported studies have used 3,3′-
dichlorobenzidine (DAB) IHC-based images for FD ana-
lysis. Also, these studies did not take into account the
tumor microenvironment that might provide valuable
biologic information relevant to prognosis. DAPI-based
nuclear staining is more robust than DAB IHC-based
techniques since it is not affected by antibody specificity
issues. Also DAPI staining is relatively easy to perform
that protein-based IHC since protein is more sensitive
than DNA to pre-analytical variables, particularly when
the motive is to preserve overall DNA structure ratherthan specific base pairs. Also, DAPI staining allows for
multiplexing of diverse stains, allowing for staining of
additional proteins that can, e.g. discriminate the tumor
(PCK) and stromal (vimentin) compartments [21]. Inter-
estingly, we found that nFD scores from the stromal or
tumor compartment alone did not show a significant
association with survival. However, a robust association
with survival was observed when nFD from the whole
tissue core (tumor plus stroma) was considered.
In order to understand how well digital nFD-based histo-
pathological analysis correlates with expert pathological as-
sessment of stromal morphological parameters associated
with survival, we compared LI, scored by a pathologist,
with nFD scores. We also studied the relationship between
nFD and tumor proliferation in order to evaluate if nFD
correlated with tumor-associated prognostic features. LI
has been previously reported to be associated with progno-
sis in OSCC [24-26] and was significantly associated with
both DSS and OS in our OSCC cohort as well (Additional
file 1: Figure S1). We observed that high nFD was associ-
ated with increased LI in the stroma and cell proliferation
in the tumor. We believe that high nFD tumor and stroma
might reflect increased proliferation in the tumor and the
presence of infiltrating immune cells in the stroma. Both
have been shown to be associated with improved prognosis
attributed to increased susceptibility to radiotherapy. We
found that patients with high nFD scores have significantly
better survival when treated with post-operative radio-
therapy compared to patients with low nFD (Figure 3b).
Although further investigation is required, nFD analysis
may represent a summary measure incorporating tumor
proliferation and the immune involvement that predicts
response to radiotherapy [30]. Therefore, high nFD might
represent a state where high proliferation renders tumor
cells sensitive to radiotherapy and dying cells are cleared
by the infiltrating immune cells, creating a “perfect storm”
for the tumor.
Conclusions
The histopathological scoring system proposed by
Brandwein-Gensler et al. is a powerful tool but its broad
implementation may be limited by its labour inten-
siveness and the requirement for extensive training.
Additionally, consistency of scoring is a substantial risk
given the high degree of inter-observer variability in
other oral histopathology-based systems, among pathol-
ogists [31,32]. Digital pathology-based nFD scoring
incorporates multiple biomarkers and therefore might
provide a more reliable and objective indicator of
prognosis compared to single biomarker-based assays.
We believe that a comprehensive approach to the
analysis of tumor microenvironment, such as the one
presented here, will improve prognostication and out-
comes in OSCC.
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curves for DSS in patients stratified by high and low (LI).
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